ASX ANNOUNCEMENT Brisbane, 1st May, 2017 ADMEDUS HSV-2 PHASE IIa RESULTS WEBINAR • Admedus investor webinar Thursday, 4 May 2017 • 9am AEST Sydney/Melbourne/Brisbane time; 7am AWST Perth time Admedus Limited (ASX:AHZ) today announced that it will hold an investor webinar on Thursday, 4 May 2017 to present the results of the HSV-2 Phase IIa program and provide a business overview on the rest of its immunotherapies programs including the HPV treatment program and its work in the area of RNA vaccines. The webinar details Date: 4 May, 2017 Time: 9am Australian Eastern Standard Time (AEST); 7am Australian Western Standard Time (ASWT) Please register to attend the webinar at: https://attendee.gotowebinar.com/register/2780413500734718467 Follow us: Twitter: @Admedus Facebook: www.facebook.com/pages/Admedus Website: www.admedus.com
ASX ANNOUNCEMENT Brisbane, 1st May, 2017 ADMEDUS HSV-2 PHASE IIa...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
0.000(0.00%) |
Mkt cap ! $292.1M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.35 | $15.00 | $47.17K | 3.102K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 350 | $15.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.19 | 60 | 1 |
View Market Depth
| Last trade - 11.50am 31/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |